The Role of Hypomethylating Agents Prior to Allogeneic Hematopoietic Stem Cells Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome
Background & Aims. The aim of the study was to evaluate the efficacy and safety of azacytidine and decitabine prior to allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), chronic myelomonocytic leukemia and juvenile myel...
Main Authors: | VN Ovechkina, SN Bondarenko, EV Morozova, IS Moiseev, AA Osipova, TL Gindina, AI Shakirova, TA Bykova, AD Kulagin, IA Samorodova, EV Karyakina, EA Ukrainchenko, LS Zubarovskaya, BV Afanas’ev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Practical Medicine Publishing House
2017-07-01
|
Series: | Kliničeskaâ onkogematologiâ |
Subjects: | |
Online Access: | http://bloodjournal.ru/wp-content/uploads/2017/09/7_1.pdf |
Similar Items
-
Resistance to Hypomethylating Agents in Myelodysplastic Syndrome and Acute Myeloid Leukemia From Clinical Data and Molecular Mechanism
by: Guangjie Zhao, et al.
Published: (2021-09-01) -
Hypomethylating Agents in Oncohematology
by: AD Shirin,, et al.
Published: (2016-10-01) -
Acute Myeloblastic Leukemia and Myelodysplastic Syndrome: Azacitidine for Prophylactic and Preventive Purposes after Allogeneic Hematopoietic Stem Cell Transplantation
by: VN Ovechkina, et al.
Published: (2017-01-01) -
Clinical Results of Hypomethylating Agents in AML Treatment
by: Marjan Cruijsen, et al.
Published: (2014-12-01) -
INFECTIONS IN MYELODYSPLASTIC SYNDROME IN RELATION TO STAGE AND THERAPY
by: Giuseppe Leone, et al.
Published: (2018-07-01)